BCLI - BrainStorm Cell Therapeutics GAAP EPS of -$0.40 beats by $0.16 April, 01 2024 08:44 AM Brainstorm Cell Therapeutics Inc. 2024-04-01 08:44:27 ET More on BrainStorm Cell Therapeutics BrainStorm submits SPA request to FDA for Phase 3 study design Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics Historical earnings data for BrainStorm Cell Therapeutics Financial information for BrainStorm Cell Therapeutics For further details see: BrainStorm Cell Therapeutics GAAP EPS of -$0.40 beats by $0.16